Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
. --------------------------------------------------------------------------------------------------------------------------------------- Job description: We are seeking applications for a full-time Assistant Professor having experience in the field of genetics and pre-breeding with good...
-
, teaching, and clinical care. The Department has four full-time PhD scientists, and two clinician-investigators, all with joint or adjunct appointments in various basic science departments. In 2023, the UIC
-
professor specialized in algal physiology and biotechnology (microalgae, cyanobacteria, seaweeds). The successful candidate will contribute actively to the development of innovative teaching methodologies and
-
Ref. Number: 8986 (*gn=gender neutral) The Institute of Physiological Chemistry & Pathobiochemistry of the University of Münster offers a position with the possibility to do a doctorate, initially
-
to teaching or other training activities (if applicable) Criteria of the candidate: PhD in the field of plant-microbe interac ons, industrial microbiology, crop physiology or related fields. Strong publica
-
experimental or computational systems and methods to understand human physiology, biomedical researchers and engineers designing or optimizing therapies, assays, devices or procedures to diagnose or treat
-
. The department employs approx. 500 people from all over the world, and they make use of the department's modern laboratory-, core- and animal facilities. The Department of Biomedicine focuses on innovation
-
receptor (GPCR) signaling in human physiology and disease to develop novel therapeutic strategies. The G Protein Coupled Receptor (GPCR) Collaborative is a recently established St Jude-funded national
-
physiology and aging; (2) long-term ramifications of traumatic brain injury and concussion with emphasis on defining molecular and cellular mechanisms in the context of cell-to-cell communication. We welcome
-
that are physiologically important for a healthy immune system. We are interested in the next generation of therapeutics that will be personalized and only target the original disease process. Such treatments can only be